Vaccination coverage
Global childhood vaccination coverage in 2023%
Initial infant doses saw widespread uptake, reaching 89% for DTPcv1 and 87% for BCG, but coverage plunged to 38% for the final HPV dose in females.
The numbers
| 1 | DTPcv1 (Diphtheria-tetanus-pertussis 1st dose) | 89 |
| 2 | BCG (Tuberculosis) | 87 |
| 3 | DTPcv3 (Diphtheria-tetanus-pertussis 3rd dose) | 84 |
| 4 | MCV1 (Measles 1st dose) | 83 |
| 5 | HepB3 (Hepatitis B 3rd dose) | 83 |
| 6 | Pol3 (Polio 3rd dose) | 83 |
| 7 | IPV1 (Inactivated polio 1st dose) | 83 |
| 8 | Hib3 (Haemophilus influenzae b 3rd dose) | 77 |
| 9 | MCV2 (Measles 2nd dose) | 74 |
| 10 | RCV (Rubella 1st dose) | 71 |
| 11 | PCV3 (Pneumococcal conjugate 3rd dose) | 65 |
| 12 | Rota (Rotavirus final dose) | 55 |
| 13 | HPV 1st dose (Females) | 47 |
| 14 | HepB-BD (Hepatitis B birth dose) | 45 |
| 15 | IPV2 (Inactivated polio 2nd dose) | 42 |
| 16 | HPV last dose (Females) | 38 |